BNP and NT-proBNP have a number of proven clinical applications in the general population, including improving the accuracy of clinical assessment for diagnosing cardiac failure in patients presenting with dyspnea [23],[24] and estimating prognosis in patients with an established diagnosis of cardiac failure [25]. This evidence concerns the gene NPPB and heart failure.